Lv1
30 积分 2024-01-25 加入
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
5天前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
5天前
已完结
A Phase 3 Trial of Dupilumab for People With Chronic Obstructive Pulmonary Disease and Elevated Peripheral Blood Eosinophil Counts
5天前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
5天前
已完结
Sex differences in symptoms and exacerbation rates relative to lung function trajectories in asthma and/or COPD
11天前
已关闭
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
16天前
已完结
Eosinophilic Versus Non-Eosinophilic Acute Exacerbations of COPD and Subsequent Cardiovascular Event
28天前
已完结
A Phase 3 Trial of Dupilumab for People With Chronic Obstructive Pulmonary Disease and Elevated Peripheral Blood Eosinophil Counts
29天前
已完结
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
1个月前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
1个月前
已完结
皖公网安备34019202002308
